C/O Aytu Biopharma, Inc., 373 Inverness Parkway, Suite 206, Englewood, CO
Summary
The estimated net worth of Christopher Brooke is at least $2.18M dollars as of August 15, 2023. Christopher Brooke is the Chief Operating Officer of AYTU BIOPHARMA, INC and owns shares of AYTU BIOPHARMA, INC (AYTU) stock worth about $2.18M.
Insider Transactions Reported by Christopher Brooke:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.